Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients.
Int J Cancer. 2002 Mar 20;98(3):415-8. doi: 10.1002/ijc.10151.
Int J Cancer. 2002.
PMID: 11920593